Methocarbamol in the Therapy of Tetanus
| Autor: | Phillip H. Tenney, Robert A. Utterback |
|---|---|
| Rok vydání: | 1963 |
| Předmět: |
medicine.medical_specialty
Pediatrics Adolescent Nursing Disease Tetanus Antitoxin complex mixtures Arts and Humanities (miscellaneous) Humans Medicine Preventive healthcare Geriatrics Methocarbamol Tetanus business.industry Mortality rate Toxoid medicine.disease Breast Feeding Injections Intravenous Amobarbital Neurology (clinical) Tracheotomy business Breast feeding medicine.drug |
| Zdroj: | Archives of Neurology. 9:555-560 |
| ISSN: | 0003-9942 |
| DOI: | 10.1001/archneur.1963.00460110123013 |
| Popis: | Introduction Tetanus is one of the most dreaded complications of wounds 1 and continues to be a serious clinical problem in some areas of the world. In areas where some form of preventive medicine is practiced for even the poorest members of the community, tetanus toxoid has made the disease a rarity, a clinical curiosity. It should be noted, though, where tetanus does occur the mortality rate remains high. Neither tetanus antitoxin nor antibiotics have improved mortality greatly in those who developed the typical symptoms. 6 For example, though the US Army experienced in World War II only 12 cases of tetanus, five of these 12 resulted in death from tetanus. 9 It seems clearly established that there is a correlation between the length of time elapsing from the date of exposure until the first clinical sign and the prognosis for the case. 4,5,8 The shorter the length of time |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|